| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Chief Operating Officer
1 company
Campbell Bradley L is a President And CEO at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $14.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,940 | $10.00 | $109,426.26 | -1.8% | -16.7% | +11.6% | |
| Jan 3, 2022 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,470 | $11.86 | $64,880.22 | -1.3% | -20.1% | -1.5% | |
| Dec 22, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 3,000 | $11.70 | $35,095.50 | -0.7% | -16.9% | +1.6% | |
| Dec 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,515 | $11.00 | $115,706.01 | -2.2% | -23.6% | +14.3% | |
| Nov 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,515 | $11.32 | $119,053.98 | -2.2% | -18.3% | -10.1% | |
| Oct 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,515 | $10.00 | $105,150.00 | -2.2% | +14.5% | +2.5% | |
| Sep 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,515 | $11.50 | $120,904.62 | -2.2% | -8.3% | -1.0% | |
| Aug 5, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 21,028 | $10.02 | $210,671.12 | -4.4% | +22.9% | +21.1% | |
| Jun 7, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $10.01 | $105,207.29 | -2.2% | +12.9% | -16.4% | |
| May 3, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $10.27 | $107,970.37 | -2.5% | -8.6% | -32.1% |